Literature DB >> 22047197

Magnesium sulfate does not protect spinal cord against ischemic injury.

Jinyoung Hwang1, Jinhee Kim, Sanghyon Park, Sukju Cho, Seongjoo Park, Sunghee Han.   

Abstract

OBJECTIVE: We tested various doses of MgSO(4) to investigate the effect of Mg on a spinal cord ischemia.
METHODS: Rats were treated with either MgSO(4) (30, 100, or 300 mg/kg; group Mg(low), group Mg(medium), group Mg(high), respectively, n = 10 for each) or saline (control group; n = 10) before ischemia. Spinal cord ischemia was induced using a balloon-tipped catheter placed on proximal descending aorta. During surgery, hemodynamic variables were recorded before ischemia, during aortic occlusion and after reperfusion. Neurologic function was assessed using the motor deficit index (MDI; 0 = normal, 6 = complete paralysis) until seven days after reperfusion, and histologic examination of spinal cord was performed.
RESULTS: After reperfusion, the mean arterial pressure in the group Mg(high) was significantly lower than other groups. Compared to the control group, the groups Mg(low) and Mg(medium) did not show any difference in MDI and the group Mg(high) showed significantly higher MDI. The number of normal motor neurons was similar among other groups except the group Mg(high) had a significantly fewer normal motor neurons.
CONCLUSIONS: Intravenous MgSO(4) with low or medium dose (30, or 100 mg/kg) did not improve neurological injury following spinal cord ischemia. Furthermore, higher dose of MgSO(4) (300 mg/kg) resulted in hemodynamic instability and aggravated neurologic outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22047197     DOI: 10.3109/08941939.2011.589884

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  1 in total

1.  Monitoring somatosensory evoked potentials in spinal cord ischemia-reperfusion injury.

Authors:  Yiming Ji; Bin Meng; Chenxi Yuan; Huilin Yang; Jun Zou
Journal:  Neural Regen Res       Date:  2013-11-25       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.